Trivant Custom Portfolio Group, LLC Abb Vie Inc. Transaction History
Trivant Custom Portfolio Group, LLC
- $173 Billion
- Q3 2024
A detailed history of Trivant Custom Portfolio Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Trivant Custom Portfolio Group, LLC holds 100 shares of ABBV stock, worth $20,047. This represents 0.01% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$20,047
Previous $17.2 Million
15.14%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding ABBV
# of Institutions
3,773Shares Held
1.28BCall Options Held
13MPut Options Held
9.82M-
Vanguard Group Inc Valley Forge, PA171MShares$34.2 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.6 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.7 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.74 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $354B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...